Zydus Cadila on Thursday launched the most affordable generic version of Gilead's antiviral medication remdesivir in India to treat COVID-19 patients. The Ahmedabad-based drugmaker has priced it at ₹2,800 per 100mg vial and will sell it under brand name Remdac. Zydus is the fifth company to start a remdesivir copy in India after Hetero Labs, Cipla, Mylan, and Jubilant Life Sciences.